Table 9:

Characteristics of the Ontario Population—Patients Who Received Fluoropyrimidines From 2014/2015 to 2018/2019 in Ontario (N = 38,225)

Patient Characteristics	Mean Value
Age	63.6 years
Sex
Male	49.2%
Female	50.8%
Type of cancer
Colorectal	40%
Breast	22%
Upper gastrointestinal	10%
Other (e.g., pancreatic, prostate, skin, lymphoid)	28%
Fluoropyrimidine prescribed
5-Fluorouracil alone	66.8%
Capecitabine alone	25.1%
Both	8.1%

Source: Data prepared in March 2020 by Ontario Health (Cancer Care Ontario) using Ontario Cancer Registry, Cancer Activity Level Reporting and Ontario Drug Benefit datasets.